Skip to main content
Government of Quebec
Institut national de santé publique du Québec
Français
FR
Home
Navigation principale
The Institute
The Institute
About us
About us
Products and services offered
Back
Contact us
Contact us
Workplaces
Back
Exit
Back
Expertise
Expertise
Information management and analysis
Information management and analysis
Deprivation
Deprivation
Indices of multiple and multidimensional deprivation
Material and Social Deprivation Index
Back
Health of linguistic communities
Health of linguistic communities
Health Profile of Linguistic Communities in Québec
Back
Back
Individual and community development
Individual and community development
Perinatal and early childhood
Perinatal and early childhood
From Tiny Tot to Toddler
Back
Back
Lifestyles and prevention of chronic illnesses
Lifestyles and prevention of chronic illnesses
Healthy eating and active lifestyle
Healthy eating and active lifestyle
Health-promoting environments
TOPO
Back
Psychoactive substances, tobacco and gambling
Psychoactive substances, tobacco and gambling
Drugs and medicines
Tobacco and electronic cigarettes
Back
Back
Laboratories and testing services
Infectious diseases
Infectious diseases
Respiratory infectious diseases
Respiratory infectious diseases
Données des virus respiratoires
COVID-19 (coronavirus)
Back
Prevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections
Nosocomial infections
Medical Device Reprocessing
Back
Travel-health
Travel-health
Health tips for travellers
Back
Zoonoses and emerging diseases
Zoonoses and emerging diseases
Diseases transmitted by ticks
Back
Back
Occupational health
Occupational health
Work-related respiratory diseases
Work-related respiratory diseases
Asbestos
Back
Psychosocial risks in the workplace
Psychosocial risks in the workplace
Let's get started
Back
Back
Indigenous Health
Indigenous Health
Research Monitoring
Research Monitoring
Methodology for Indigenous Health Research Monitoring
Back
Nunavik Inuit Health Survey 2004
Back
Environmental health and toxicology
Environmental health and toxicology
Water, food, soil and products
Water, food, soil and products
Per- and polyfluoroalkyl substances (PFAS)
Back
Air quality, environmental noise and non-ionizing radiation
Air quality, environmental noise and non-ionizing radiation
Air quality
Back
Surveillance, skills development, and evaluation approaches in environmental health
Surveillance, skills development, and evaluation approaches in environmental health
Post-Disaster Mental Health Impacts Surveillance Toolkit
Back
Back
Safety, violence and injury prevention
Safety, violence and injury prevention
Community safety promotion
Community safety promotion
Methods and tools
Back
Prevention of interpersonal violence
Prevention of interpersonal violence
Sexual Violence
Rapport québécois sur la violence et la santé
Back
Back
Exit
Back
Services
Services
Centre de toxicologie du Québec
Centre de toxicologie du Québec
About the CTQ
About the CTQ
Contact us
Back
Services
Services
Test catalog
Analysis request forms
Shipping samples
PayPal Bill Payment
Back
External quality assessment schemes
External quality assessment schemes
AMAP: AMAP Ring Test for Persistent Organic Pollutants in Human Serum
Creatinine: Interlaboratory Comparison Program for Measurement of Serum Creatinine
OSEQAS: External Quality Assessment Scheme for Organic Substances in Urine
PCI: Interlaboratory Comparison Program for Metals in Biological Matrices
QMEQAS: Quebec Multielement External Quality Assessment Scheme
Back
Back
Infectious diseases
Infectious diseases
Blood-Borne Infection Risk Assessment Unit
Blood-Borne Infection Risk Assessment Unit
Risk Assessment Process
Rights and Responsibilities
Back
Back
Exit
Back
Publications
Publications
Publications
Subscribe to INSPQ's mailing lists
Exit
Back
Surveys
Surveys
Respiratory viruses survey
Respiratory viruses survey
Complete the survey (period May 18 to 24, 2025)
Back
Exit
Back
Search
Search by keywords
Search by keywords
Caroline Quach-Thanh
Publications
INSPQ
2025
Stratégie de prévention des infections pneumococciques au Québec avec l’introduction des nouveaux vaccins conjugués
Vaccination contre la COVID-19 et la grippe pour la saison 2025-2026
Vaccination contre la mpox (variole simienne) dans un contexte d’augmentation de la circulation du clade 1 du virus en Afrique
Recrudescence de la coqueluche au Québec en 2024 : évaluation de la stratégie de vaccination contre cette maladie
2024
Vaccination contre la COVID-19 : Recommandations pour l’automne 2024
Avis complémentaire sur le choix des vaccins influenza pour l’immunisation des personnes âgées et vulnérables durant la saison 2024-2025 au Québec
2023
Administration de la deuxième dose du vaccin contre la variole simienne (mpox)
2022
Utilisation des vaccins conjugués contre les pneumocoques pour les patients immunodéprimés
Vaccination contre la variole simienne
Impact des maladies chroniques sur la prescription des antibiotiques selon les guides cliniques dans la communauté
Avis concernant l’usage d’une dose de rappel du vaccin Comirnaty pédiatrique contre la COVID-19 chez les enfants de 5 à 11 ans
Impact des maladies chroniques sur les taux d’utilisation des antibiotiques dans la communauté
Vaccination contre la COVID-19 chez les jeunes âgés de 5 à 11 ans au Québec
Stratégie vaccinale contre la COVID-19 à préconiser au Québec en 2022 et pertinence d’une 2e dose de rappel pour certains groupes vulnérables
Administration des doses subséquentes d’un vaccin contre la COVID-19 chez les personnes ayant développé une péricardite ou une myocardite
2021
Pertinence d’une dose de rappel d’un vaccin contre la COVID 19 pour les différentes catégories d’adultes au Québec
Vaccination des personnes de moins de 30 ans contre la COVID-19 dans le contexte de la survenue de myocardites et péricardites après l’administration des vaccins à ARN messager
2020
COVID-19 : Étude de séroprévalence chez des travailleurs de la santé de centres hospitaliers au Québec
2018
Faisabilité d’une surveillance de la résistance aux antibiotiques à partir des données de laboratoire extraites par un logiciel intégratif en centre hospitalier
2017
Avis sur l’utilisation des vaccins pneumococciques conjugués 13-valent (VPC-13) et polysaccharidiques (VPP-23) pour la prévention des infections invasives à pneumocoque et les pneumonies d’origine communautaire chez les personnes âgées de 65 ans et plus
Central Line–Associated Bloodstream Infections in Intensive Care Units: surveillance 2013-2014
Central Line–Associated Bloodstream Infections in Intensive Care Units: surveillance 2013-2014
Central Line–Associated Bloodstream Infections in Intensive Care Units: Surveillance 2015-2016
Central Line–Associated Bloodstream Infections in Intensive Care Units: Surveillance 2015-2016
2016
Bactériémies sur cathéters centraux aux soins intensifs : résultats de surveillance 2015-2016
Bactériémies sur cathéters centraux aux soins intensifs : résultats de surveillance 2015-2016
Central Line–Associated Bloodstream Infections in Intensive Care Units in Québec surveillance results : 2014–2015
Central Line–Associated Bloodstream Infections in Intensive Care Units in Québec surveillance results : 2014–2015
2015
Bactériémies sur cathéters centraux aux soins intensifs : résultats de surveillance 2014-2015
Bactériémies sur cathéters centraux aux soins intensifs : résultats de surveillance 2014-2015
2014
Bactériémies sur cathéters centraux aux soins intensifs : résultats de surveillance 2013-2014
Bactériémies sur cathéters centraux aux soins intensifs : résultats de surveillance 2013-2014
2013
Étude sur la surveillance et les stratégies de prévention des bactériémies associées aux cathéters centraux aux soins intensifs 2010-2011 appliquées dans les centres hospitaliers de soins aigus du Québec
Étude sur la surveillance et les stratégies de prévention des bactériémies associées aux voies d'accès en hémodialyse 2010-2011 appliquées dans les centres hospitaliers de soins aigus du Québec
2009
Surveillance des bactériémies nosocomiales panhospitalières : avril 2007-mars 2008
Surveillance provinciale des bactériémies nosocomiales sur cathéters centraux aux soins intensifs : avril 2007-mars 2008
2008
Surveillance provinciale des bactériémies nosocomiales sur cathéters centraux aux soins intensifs : avril 2006-mars 2007
2006
Surveillance provinciale des bactériémies nosocomiales sur cathéters centraux aux soins intensifs : avril 2005-mars 2006
Surveillance provinciale des bactériémies nosocomiales sur cathéters centraux aux soins intensifs : octobre 2003-mars 2005
Articles
2022
Chronic diseases and compliance with provincial guidelines for outpatient antibiotic prescription in cases of otitis media and respiratory infections: a population-based study of linked data in Quebec, Canada, 2010-2017
Chronic diseases and variations in rates of antimicrobial use in the community: a population-based analysis of linked administrative data in Quebec, Canada, 2002-2017
Evaluation of the 2018-2019 vaccine effectiveness against medically attended influenza-like illness using medical records and claims data
2018
Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada
Respiratory Viruses and Treatment Failure in Children With Asthma Exacerbation
Serratia marcescens outbreak in a neonatal intensive care unit (NICU): new insights from next-generation sequencing applications
Early predictors of Guillain-Barré syndrome in the life course of women
2017
Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasons.
Early predictors of Guillain-Barre syndrome in the life course of women.
Congenital microcephaly in Quebec: baseline prevalence, risk factors and outcomes in a large cohort of neonates.
Exploring the acceptability of the available pneumococcal conjugate vaccines in Canadian health care professionals and immunization experts.
Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis.
Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care
2016
Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Quebec, 2010-15.
Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings.
Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus epidermidis Outbreak in a Neonatal Intensive Care Unit.
Temporal Changes in Pediatric Gastroenteritis after Rotavirus Vaccination in Quebec.
Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review.
2015
Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
Improving quality of data extractions for the computation of patient-days and admissions
A Simulation Study to Assess Indicators of Antimicrobial Use as Predictors of Resistance: Does It Matter Which Indicator Is Used?
Predicting Antimicrobial Resistance Prevalence and Incidence from Indicators of Antimicrobial Use: What Is the Most Accurate Indicator for Surveillance in Intensive Care Units?
2014
Measuring antimicrobial use in hospitalized patients: a systematic review of available measures applicable to paediatrics
How many individuals with asthma need to be vaccinated to prevent one case of invasive pneumococcal disease?
Influenza immunization of chronically ill children in pediatric tertiary care hospitals
2012
Healthcare-associated bloodstream infections secondary to a urinary focus: the Québec provincial surveillance results
2011
Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children
2010
Contagious period for pandemic (H1N1) 2009